查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無晶體眼市場規模、佔有率和成長分析（按類型、最終用戶、治療方法和地區分類）—2026-2033年產業預測
市場調查報告書
商品編碼
1916041

無晶體眼市場規模、佔有率和成長分析（按類型、最終用戶、治療方法和地區分類）—2026-2033年產業預測

Aphakia Market Size, Share, and Growth Analysis, By Type (Acquired Aphakia, Congenital Aphakia), By End User (Hospitals, Ophthalmic clinics), By Treatment, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球無晶體眼市場規模預計在 2024 年達到 20 億美元，從 2025 年的 22.3 億美元成長到 2033 年的 52.5 億美元，在預測期（2026-2033 年）內複合年成長率為 11.3%。

白內障病例的增加、人口老化以及因意外事故和運動傷害導致的眼外傷發生率上升，正推動全球無晶體眼市場顯著成長。這些因素會導致水晶體脫位，因此需要進行無晶體眼治療。晶狀體設計的創新和治療效果的提升也促進了市場需求。大眾對眼健康和早期療育意識的提高也發揮了關鍵作用。政府措施和行動診所的普及提高了醫療服務的可近性，推動了治療的廣泛應用。此外，人工智慧、機器學習、物聯網和擴增實境等先進技術的融合，透過實現更精準的診斷、更完善的外科醫生培訓和更即時的病患監測，正在改變市場格局，最終改善手術效果和患者滿意度。

全球無晶體眼市場促進因素

全球無晶體眼市場受到白內障手術技術進步的顯著影響。白內障手術透過摘除眼球的天然水晶體，導致對有效無晶體眼治療方法的需求不斷成長。隨著越來越多的醫療專業人員將白內障手術作為高風險手術患者的首選治療方案，該市場持續擴張。此外，各地醫療服務可近性的提高也導致無晶體眼病例增加，從而推動了市場成長。這一趨勢表明，市場對創新解決方案的需求日益成長，以應對無晶體眼帶來的挑戰，這為醫療產業的現有企業和新興企業都創造了成長機會。

限制全球無晶體眼市場的因素

全球無晶體眼市場面臨諸多限制因素，主要原因在於治療方案的高昂費用。無晶體眼治療通常包括人工水晶體、特殊隱形眼鏡或複雜的手術，這些治療費用可能非常昂貴。沉重的經濟負擔使得許多患者無法獲得治療。此外，製造商難以在保持價格可負擔性的同時，確保有效治療所需的精準性和安全性。因此，這些經濟因素構成了障礙，阻礙了無晶體眼患者的治療方法的廣泛應用和普及。

全球無晶體眼市場趨勢

全球無晶體眼市場正經歷強勁成長，這主要得益於患者和眼科醫生對人工水晶體（IOL）需求的不斷成長。人們對人工水晶體益處的認知不斷提高，顯著推動了人工水晶體的手術需求。此外，微創手術的趨勢，例如提高患者舒適度和縮短恢復時間，也進一步推動了市場發展。水晶體技術的創新和白內障患者數量的成長，為人工水晶體的普及應用創造了有利環境，從而改變了治療模式。這正在改變全球白內障和無水晶體眼的治療方式。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究

全球無晶體眼市場規模（按類型及複合年成長率分類）（2026-2033 年）

  • 後天性無晶體
  • 先天性無晶體

全球無晶體眼市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

  • 醫院
  • 眼科診所
  • 其他

全球無晶體眼市場規模（按治療方法和複合年成長率分類）（2026-2033 年）

  • 眼鏡
  • 隱形眼鏡
  • 人工水晶體植入術
  • 屈光矯正手術

全球無晶體眼市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Johnson & Johnson Vision（Johnson & Johnson Services Inc.）
  • Alcon Laboratories Inc.
  • Carl Zeiss AG（ZEISS International）
  • Bausch+Lomb Incorporated
  • Rayner Intraocular Lenses Limited
  • Ophtec BV
  • CooperVision Inc.
  • Hoya Corporation
  • Menicon Co. Ltd.
  • Bohus BioTech AB
  • Lifecore Biomedical, LLC
  • Mediphacos
  • Santen Pharmaceutical Co. Ltd.
  • UltraVision CLPL

結論與建議

簡介目錄
Product Code: SQMIG35A3108

Global Aphakia Market size was valued at USD 2 Billion in 2024 and is poised to grow from USD 2.23 Billion in 2025 to USD 5.25 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The global aphakia market is witnessing significant growth driven by an increase in cataract cases, a rising aging population, and a heightened incidence of eye trauma due to accidents and sports injuries. These factors lead to lens dislocation and necessitate treatment for aphakia. Enhanced lens design innovations contribute to improving treatment outcomes, further boosting demand. Growing public awareness regarding eye health and early intervention also plays a crucial role. Increased healthcare access through government initiatives and mobile clinics facilitates wider treatment adoption. Additionally, the integration of advanced technologies such as AI, machine learning, IoT, and augmented reality is transforming the market by enabling better diagnosis, training for surgeons, and real-time patient monitoring, ultimately improving surgical outcomes and patient satisfaction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global Aphakia market is significantly influenced by developments in cataract surgery, where the removal of the eye's natural lens creates a growing demand for effective aphakia treatment options. As more healthcare professionals prioritize cataract removal in patients with heightened surgical risks, the market continues to expand. Additionally, improved access to healthcare in various regions is resulting in a higher incidence of aphakia cases, thereby driving market growth. This trend highlights the increasing need for innovative solutions to address the challenges associated with aphakia, fostering opportunities for both established companies and emerging players within the healthcare industry.

Restraints in the Global Aphakia Market

The Global Aphakia market faces significant restraints primarily due to the high costs associated with treatment options. Addressing aphakia typically involves the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access to treatment for many patients. Furthermore, manufacturers struggle to strike a balance between maintaining affordability and delivering the precision and safety essential for effective aphakia management. As a result, these economic factors create barriers that hinder the widespread adoption and availability of necessary treatments for individuals affected by this condition.

Market Trends of the Global Aphakia Market

The Global Aphakia market is experiencing robust growth, driven by a heightened demand for intraocular lenses (IOLs) among both patients and ophthalmologists. This rising awareness about the advantages of IOLs is significantly propelling interest in intraocular lens-based surgeries. Additionally, the trend towards minimally invasive procedures, which offer enhanced patient comfort and expedited recovery times, is further fueling the market. Innovations in lens technology and the increasing prevalence of cataracts are contributing to a favorable environment for IOL adoption, leading to a shift in treatment paradigms and transforming the landscape of cataract and aphakia management worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies

Global Aphakia Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Acquired Aphakia
  • Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ophthalmic clinics
  • Others

Global Aphakia Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Spectacles
  • Contact Lenses
  • Intraocular Lens Implantation
  • Refractive Surgery

Global Aphakia Market Size & CAGR (2026-2033)

  • North America (Type, End User, Treatment)
    • US
    • Canada
  • Europe (Type, End User, Treatment)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End User, Treatment)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End User, Treatment)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End User, Treatment)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon Laboratories Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss AG (ZEISS International)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch + Lomb Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rayner Intraocular Lenses Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ophtec BV
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperVision Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hoya Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Menicon Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bohus BioTech AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifecore Biomedical, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediphacos
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Santen Pharmaceutical Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UltraVision CLPL
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations